Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24035759)

1.

Use of proton pump inhibitors and subsequent risk of celiac disease.

Lebwohl B, Spechler SJ, Wang TC, Green PH, Ludvigsson JF.

Dig Liver Dis. 2014 Jan;46(1):36-40. doi: 10.1016/j.dld.2013.08.128. Epub 2013 Sep 12.

2.

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.

Lam JR, Schneider JL, Zhao W, Corley DA.

JAMA. 2013 Dec 11;310(22):2435-42. doi: 10.1001/jama.2013.280490.

PMID:
24327038
3.

Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.

Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ.

Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734. Review.

PMID:
23318494
4.

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA.

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978.

5.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Herzig SJ, Howell MD, Ngo LH, Marcantonio ER.

JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722.

PMID:
19470989
6.

What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?

Patel AJ, Som R.

Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):356-60. doi: 10.1093/icvts/ivs483. Epub 2012 Dec 2. Review.

7.

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.

Vestergaard P, Rejnmark L, Mosekilde L.

Calcif Tissue Int. 2006 Aug;79(2):76-83. Epub 2006 Aug 15.

PMID:
16927047
8.

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

Corley DA, Kubo A, Zhao W, Quesenberry C.

Gastroenterology. 2010 Jul;139(1):93-101. doi: 10.1053/j.gastro.2010.03.055. Epub 2010 Mar 27.

9.

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Bradley MC, Murray LJ, Cantwell MM, Hughes CM.

Br J Cancer. 2012 Jan 3;106(1):233-9. doi: 10.1038/bjc.2011.511. Epub 2011 Nov 22.

10.

Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.

Abrahamsen B, Vestergaard P.

Bone. 2013 Nov;57(1):269-71. doi: 10.1016/j.bone.2013.08.013. Epub 2013 Aug 22.

PMID:
23973557
11.

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75. doi: 10.1002/pds.1715.

PMID:
19235776
12.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Yu EW, Bauer SR, Bain PA, Bauer DC.

Am J Med. 2011 Jun;124(6):519-26. doi: 10.1016/j.amjmed.2011.01.007.

13.
14.

Examination of selected clinical factors and medication use as risk factors for pneumonia during stroke rehabilitation: a case-control study.

Marciniak C, Korutz AW, Lin E, Roth E, Welty L, Lovell L.

Am J Phys Med Rehabil. 2009 Jan;88(1):30-8. doi: 10.1097/PHM.0b013e3181909b73.

PMID:
19096289
15.

Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.

Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, Kumar S.

Ann Neurol. 2014 Nov;76(5):712-8. doi: 10.1002/ana.24262. Epub 2014 Sep 17.

PMID:
25164323
16.

Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.

Martin RM, Lim AG, Kerry SM, Hilton SR.

Aliment Pharmacol Ther. 1998 Aug;12(8):797-805.

17.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

18.

The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.

Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB.

Crit Care Med. 2010 Apr;38(4):1197-205. doi: 10.1097/CCM.0b013e3181d69ccf.

PMID:
20173630
19.

The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.

El-Serag HB, Aguirre T, Kuebeler M, Sampliner RE.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1255-60.

20.

The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.

El-Serag HB, Fitzgerald S, Richardson P.

Am J Gastroenterol. 2009 Sep;104(9):2161-7. doi: 10.1038/ajg.2009.312. Epub 2009 Jun 30.

PMID:
19568229
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk